Integer Holdings today announced that it has appointed three new executives to its leadership team.
The appointments come as part of a planned transition due to retirements. Margaret Cathy is being promoted to senior VP of quality and regulatory affairs; Andrew Senn is being promoted to senior VP of strategy and business development and McAlister Marshall is was named senior VP and general counsel, chief ethics and compliance officer and corporate secretary.
Cathy replaces Joseph Flanagan who announced his retirement from the company in December. She previously served as the company’s VP of quality and regulatory and has been with the company since 2004. Prior to joining Integer, Cathy was a quality and regulatory leader for the European Region at Sola International, which is now Carl Zeiss.
Senn’s promotion follows the retirement announcement of Tony Borowicz, senior VP of strategy, business development and investor relations, who plans to retire in early 2023. Senn has been with Integer got 15 years and has held numerous leadership roles in marketing, strategy, R&D and commercial sales. He most recently served as VP of marketing for the cardio & vascular product category at the company. Prior to joining the company, he was the director of program management for St. Jude Medical.
Marshall has served as the company’s interim general counsel since September 2021. He was previously the senior VP, general counsel and chief administrative officer at The Brink’s Company. He has also served as VP, general counsel and secretary at Tredegar Corporation.
“I’m thrilled to have these exemplary leaders on Integer’s executive leadership team,” CEO Joe Dziedzic said in a news release. “Their collective expertise, skillsets and critical knowledge of the medical device industry complement our existing ELT, and the fact that all have held leadership roles within Integer is a testament to the strength of our culture and the breadth and depth of talent and capabilities within our organization.”